---
title: Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation
nct_id: NCT04695301
overall_status: COMPLETED
phase: NA
sponsor: Hospital Israelita Albert Einstein
study_type: INTERVENTIONAL
primary_condition: COVID-19
countries: Brazil
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04695301.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04695301"
ct_last_update_post_date: 2022-02-11
last_seen_at: "2026-05-12T07:15:48.784Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation

**NCT ID:** [NCT04695301](https://clinicaltrials.gov/study/NCT04695301)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 25
- **Lead Sponsor:** Hospital Israelita Albert Einstein
- **Conditions:** COVID-19, Coronavirus Infections, Exercise Therapy
- **Start Date:** 2020-07-01
- **Completion Date:** 2021-10-01
- **CT.gov Last Update:** 2022-02-11

## Brief Summary

COVID-19, an acute respiratory disease caused by coronavirus-2 (SARS-CoV-2), and in most cases, causes mild to moderate symptoms of fever, cough and dyspnea. However, a not insignificant portion, given the total number of people affected, will present symptoms of severe acute respiratory failure and multiple organ failure, requiring hospitalization under intensive care, use of mechanical ventilation, prolonged period of immobilization and, consequently, physical, cognitive and psychological damage, which may affect survivors for a long period after hospitalization. All of these factors are known to have an impact on various areas of life: personal, social and economic, which makes the need for continued specific care after hospital discharge relevant. In this context, the role of rehabilitation programs is fundamental, aiming not only at a safer dehospitalization, but also at the continuity of care with the objective of restoring the biopsychosocial skills of these individuals, allowing functional independence for activities of daily life and a shorter return physical and social activities performed before the disease. However, the big challenge for the health system is how to offer this on a large scale. Therefore, knowing the clinical and functional profile of these patients at discharge and verifying the viability of a digital platform for rehabilitation and monitoring of these patients is the first step to allow the creation of a new form of continuity of care and access to affected patients with serious diseases such as COVID-19 and other syndromes capable of generate functional impairment. Therefore,the investigators objective is to characterize and monitor the functional profile and exercise capacity of patients affected by COVID-19 at the hospital discharge, as well as to verify the viability and compliance of patients to the use of a digital platform for the application of a distance rehabilitation program.

## Detailed Description

The investigators proposal is to characterize and evaluate the impact of the disease on the clinical, functional and social aspects in these patients affected by COVID-19 and to propose the continuity of specific care after hospital discharge with a physical rehabilitation program through a digital platform, remotely for a period of 3 months. The proposed hypothesis is that patients convalescing from COVID-19 and undergoing the rehabilitation program will have a gain in functional skills and quality of life. The professional team involved in this study will be responsible for managing, monitoring and evaluating the participating patients and monitoring the performance of the proposed functional exercises.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 80 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Men and women affected by COVID-19
* over 18 years of age, admitted to HIAE partner hospitals

Exclusion Criteria:

* presence of a physical or cognitive condition that makes it impossible or contraindicated to perform the 2-minute stride test and perform the proposed exercises.
* Patients with a more severe clinical and functional profile,
* Pregnant women
```

## Arms

- **digital platform rehabilitation** (EXPERIMENTAL) — Rehabilitation program through a digital platform for 3 months
- **control group** (EXPERIMENTAL) — Patients without access to technology will do the exercises using booklets and will compose the control group

## Interventions

- **Rehabilitation protocol through a digital platform** (OTHER) — During 3 months the patients will participate in a rehabilitation program through a digital platform

## Primary Outcomes

- **Characterize the clinical function profile of patients affected by COVID-19** _(time frame: 3 months)_ — Characterize the clinical functional profile of patients affected by COVID-19 by data from medical records
- **Characterize the exercise capacity of patients affected by COVID-19** _(time frame: 3 months)_ — Characterize the exercise capacity of patients affected by COVID-19 by 2-minute step test

## Secondary Outcomes

- **Assess clinical and demographic data** _(time frame: 3 months)_
- **Assess functional level at hospital discharge** _(time frame: 3 months)_
- **Assess patient compliance of the rehabilitation program using the digital platform** _(time frame: 3 months)_

## Locations (1)

- Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP), São Paulo, Brazil

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.instituto israelita de ensino e pesquisa albert einstein 's (iiep)|são paulo||brazil` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04695301.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04695301*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*
